Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K report on August 1, 2019, to announce its financial results for the second quarter ended June 30, 2019. This filing primarily serves to furnish a press release detailing these results. Investors should note that the information provided in this 8-K, specifically the attached press release, is furnished under Item 2.02 and is not considered "filed" for regulatory purposes under Section 18 of the Exchange Act. This means it does not carry the same legal liabilities as filed information but serves as a public disclosure of the company's performance for the period. The key takeaway for investors is the release of the company's quarterly performance metrics. While the 8-K itself does not contain the detailed financial figures, it directs readers to the furnished press release (Exhibit 99.1) for the full financial picture. Investors are encouraged to review Exhibit 99.1 for specific revenue, earnings, and other operational highlights that would typically be found in a quarterly earnings announcement to assess the company's performance and outlook.
Key Highlights
- 1IDEXX Laboratories announced its second quarter financial results for the period ended June 30, 2019.
- 2The company furnished its financial results via a press release, designated as Exhibit 99.1 to the 8-K filing.
- 3The information is furnished under Item 2.02 of Form 8-K, meaning it's not "filed" for purposes of Section 18 of the Exchange Act.
- 4This filing provides investors with access to the company's performance for the reported quarter.
- 5Investors should refer to the furnished press release (Exhibit 99.1) for specific financial and operational details.
- 6Brian P. McKeon, Executive Vice President, Chief Financial Officer and Treasurer, signed the report.